Buying Tesla Stock? Wait Until You See This...
With most investors focused on big tech, a frenzy is quietly erupting in one tiny sector, with gains like 500% in two months and 104% in a single day.
Click Here...
pixel

PHAT Insider Trading (Phathom Pharmaceuticals)

Insider Ownership Percentage: 39.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $12,945,443.30

Phathom Pharmaceuticals Insider Trading History Chart

Phathom Pharmaceuticals Share Price & Price History

$38.49
▼ -0.07 (-0.18%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
April 30th is approaching, are you prepared?
A new president’s policies always influence key stocks.
Here’s where top billionaires are investing.
pixel

Phathom Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/5/2021Azmi NabulsiCOOSell9,353$36.11$337,736.83  
4/5/2021David A SocksDirectorSell22,118$36.05$797,353.90  
4/1/2021Azmi NabulsiCOOSell5,147$37.57$193,372.79  
3/22/2021Terrie CurranInsiderSell11,513$43.32$498,743.1611,513  
3/12/2021David A SocksDirectorSell55,000$47.58$2,616,900.00  
3/10/2021David A SocksDirectorSell12,071$49.01$591,599.71  
3/1/2021Azmi NabulsiCOOSell5,373$45.85$246,352.05  
2/22/2021David A SocksDirectorSell20,140$45.66$919,592.40  
2/19/2021David A SocksDirectorSell44,876$47.18$2,117,249.68  
2/2/2021Azmi NabulsiCOOSell14,500$39.89$578,405.00
1/11/2021David A SocksDirectorSell12,835$34.92$448,198.20  
12/16/2020David A SocksDirectorSell31,446$47.53$1,494,628.38  
12/1/2020Azmi NabulsiCOOSell7,198$44.20$318,151.60  
11/11/2020David A SocksDirectorSell30,342$41.30$1,253,124.60
11/2/2020Azmi NabulsiCOOSell14,500$36.83$534,035.00  
3/31/2020Ra Capital Management, L.P.Major ShareholderBuy30,600$24.55$751,230.00  
3/27/2020Ra Capital Management, L.P.Major ShareholderBuy30,000$24.60$738,000.00  
10/29/2019Life Sciences Ix L.P. FrazierMajor ShareholderBuy1,052,631$23.56$24,799,986.36
See Full Table

SEC Filings (Institutional Ownership Changes) for Phathom Pharmaceuticals (NASDAQ:PHAT)

73.80% of Phathom Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Phathom Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/2/2021Norges Bank329,343$10.94M0.0%N/A1.137%
2/19/2021JPMorgan Chase & Co.187,006$6.21M0.0%+15.0%0.646%
2/17/2021Luminus Management LLC126,903$4.22M1.0%N/A0.438%
2/16/2021Squarepoint Ops LLC28,573$0.95M0.0%N/A0.099%
2/16/2021Pura Vida Investments LLC60,000$1.99M0.1%N/A0.207%
2/16/2021Nuveen Asset Management LLC63,006$2.09M0.0%+2.2%0.218%
2/16/2021Price T Rowe Associates Inc. MD81,021$2.69M0.0%-42.3%0.280%
2/16/2021Jefferies Group LLC247,560$8.22M0.1%N/A0.855%
2/16/2021Avidity Partners Management LP152,500$5.07M0.2%N/A0.526%
2/16/2021Janus Henderson Group PLC1,938,436$64.40M0.0%+23.6%6.692%
2/12/2021Caas Capital Management LP16,847$0.56M0.0%N/A0.058%
2/12/2021Ikarian Capital LLC100,000$3.32M0.1%N/A0.345%
2/12/2021Credit Suisse AG7,926$0.26M0.0%N/A0.027%
2/12/2021Virtus ETF Advisers LLC6,635$0.22M0.1%+6.3%0.023%
2/11/2021Trexquant Investment LP6,262$0.21M0.0%N/A0.022%
2/11/2021Northern Trust Corp131,321$4.36M0.0%-0.9%0.453%
2/11/2021Citigroup Inc.3,294$0.11M0.0%+194.6%0.011%
2/10/2021Rhumbline Advisers12,200$0.41M0.0%+11.7%0.042%
2/9/2021Wells Fargo & Company MN11,289$0.38M0.0%+30.9%0.039%
2/9/2021Bank of New York Mellon Corp43,668$1.45M0.0%-0.6%0.151%
2/8/2021Alliancebernstein L.P.11,400$0.38M0.0%-5.8%0.039%
2/5/2021BlackRock Inc.790,880$26.27M0.0%+10.3%2.730%
2/4/2021GSA Capital Partners LLP21,871$0.73M0.1%N/A0.076%
2/4/2021State of Wisconsin Investment Board14,900$0.50M0.0%-10.8%0.051%
1/28/2021Occidental Asset Management LLC12,872$0.43M0.1%N/A0.044%
1/19/2021Rhenman & Partners Asset Management AB175,000$5.81M0.5%N/A0.604%
11/13/2020Morgan Stanley1,095$40K0.0%-67.1%0.004%
11/13/2020Charles Schwab Investment Management Inc.75,787$2.78M0.0%-7.2%0.262%
11/13/2020Virtus ETF Advisers LLC6,242$0.23M0.1%-11.8%0.022%
11/12/2020JPMorgan Chase & Co.162,595$5.82M0.0%+1.5%0.561%
11/12/2020Greenspring Associates LLC230,727$8.46M13.2%-39.5%0.797%
11/12/2020Massachusetts Financial Services Co. MA16,755$0.61M0.0%-3.8%0.058%
11/10/2020State Street Corp214,307$7.86M0.0%+0.7%0.740%
11/6/2020BlackRock Inc.716,912$26.29M0.0%-1.2%2.475%
11/5/2020California Public Employees Retirement System32,724$1.20M0.0%+2.5%0.113%
11/5/2020Wells Fargo & Company MN8,627$0.32M0.0%-25.0%0.030%
10/29/2020Cambridge Investment Research Advisors Inc.16,300$0.60M0.0%N/A0.056%
10/15/2020Hamilton Lane Advisors LLC31,922$1.17M0.6%-47.1%0.110%
8/25/2020Nuveen Asset Management LLC50,038$1.65M0.0%+41.0%0.173%
8/20/2020Charles Schwab Investment Management Inc.81,668$2.69M0.0%+19.0%0.282%
8/17/2020Great West Life Assurance Co. Can871$28K0.0%N/A0.003%
8/14/2020Bank of America Corp DE4,555$0.15M0.0%-71.1%0.016%
8/14/2020BVF Inc. IL322,098$10.60M0.7%-52.4%1.112%
8/14/2020Vanguard Group Inc.699,119$23.01M0.0%+240.2%2.414%
8/14/2020Advisor Group Holdings Inc.750$25K0.0%N/A0.003%
8/13/2020Greenspring Associates LLC381,069$12.54M7.7%+5.6%1.316%
8/13/2020Athanor Capital LP21,427$0.71M0.0%N/A0.074%
8/12/2020Ensign Peak Advisors Inc850,003$27.97M0.1%+42.3%2.935%
8/12/2020Bank of Montreal Can854$26K0.0%N/A0.003%
8/12/2020Bank of New York Mellon Corp44,115$1.45M0.0%+15.4%0.152%
8/12/2020Rockefeller Capital Management L.P.17,388$0.57M0.0%N/A0.060%
8/12/2020California Public Employees Retirement System31,924$1.05M0.0%+298.7%0.110%
8/5/2020Virtus ETF Advisers LLC7,076$0.23M0.1%N/A0.024%
8/5/2020Swiss National Bank16,100$0.53M0.0%N/A0.056%
8/5/2020BP PLC23,000$0.75M0.0%N/A0.079%
8/4/2020Frazier Management LLC5,827,415$191.78M16.8%-20.0%20.115%
8/3/2020Penn Mutual Asset Management LLC86,940$2.86M2.9%N/A0.300%
7/31/2020Monarch Partners Asset Management LLC21,728$0.72M0.2%N/A0.075%
7/31/2020UBS Group AG4,177$0.14M0.0%-34.9%0.014%
7/20/2020SG Americas Securities LLC5,858$0.19M0.0%N/A0.020%
7/16/2020Hamilton Lane Advisors LLC60,299$1.98M1.1%N/A0.208%
6/19/2020State Street Corp187,308$4.84M0.0%+49.6%0.647%
5/15/2020RA Capital Management L.P.3,707,408$95.73M3.0%+1.7%12.800%
5/15/2020Invesco Ltd.2,075,685$53.59M0.0%-1.3%7.166%
5/14/2020Wells Fargo & Company MN6,299$0.16M0.0%+619.1%0.022%
5/14/2020Geode Capital Management LLC160,927$4.16M0.0%+4.9%0.556%
5/14/2020Janus Henderson Group PLC1,667,577$42.18M0.0%+13.6%5.757%
5/14/2020Legal & General Group Plc1,616$42K0.0%-23.7%0.006%
5/12/2020Citigroup Inc.3,241$83K0.0%+50.2%0.011%
5/12/2020Victory Capital Management Inc.2,089$54K0.0%+37.3%0.007%
5/12/2020FCG Advisors LLC16,300$0.42M0.1%N/A0.056%
5/11/2020Ensign Peak Advisors Inc597,492$15.43M0.1%-3.1%2.062%
5/11/2020State Street Corp187,308$4.84M0.0%+49.6%0.647%
5/6/2020Bank of New York Mellon Corp38,233$0.99M0.0%+54.2%0.132%
5/6/2020Rhumbline Advisers11,423$0.30M0.0%+63.5%0.039%
5/4/2020American International Group Inc.6,370$0.16M0.0%-5.5%0.022%
5/4/2020Victory Capital Management Inc.2,089$54K0.0%+37.3%0.007%
5/1/2020BlackRock Inc.584,946$15.10M0.0%-8.7%2.019%
5/1/2020UBS Group AG6,415$0.17M0.0%-54.5%0.022%
4/17/2020Exane Derivatives3,102$80K0.0%N/A0.011%
3/5/2020Nuveen Asset Management LLC35,345$1.10M0.0%N/A0.144%
3/3/2020Norges Bank317,300$9.88M0.0%N/A1.294%
2/20/2020Geode Capital Management LLC153,434$4.78M0.0%N/A0.625%
2/18/2020Janus Henderson Group PLC1,467,462$43.59M0.0%N/A5.982%
2/14/2020BVF Inc. IL785,851$24.47M1.9%N/A3.204%
2/14/2020RA Capital Management L.P.3,646,808$113.56M3.4%N/A14.869%
2/14/2020Bank of America Corp DE1,855$58K0.0%N/A0.008%
2/14/2020Bank of New York Mellon Corp24,794$0.77M0.0%N/A0.101%
2/14/2020Goldman Sachs Group Inc.6,492$0.20M0.0%N/A0.026%
2/14/2020Alyeska Investment Group L.P.23,141$0.72M0.0%N/A0.094%
2/14/2020UBS Group AG14,099$0.44M0.0%N/A0.057%
2/14/2020Abingworth LLP1,203,135$37.43M18.1%N/A4.905%
2/13/2020Frazier Management LLC7,284,269$226.83M38.0%N/A29.699%
2/12/2020Citigroup Inc.2,158$67K0.0%N/A0.009%
2/10/2020Bank of Montreal Can1,352$42K0.0%N/A0.006%
2/7/2020Charles Schwab Investment Management Inc.67,787$2.11M0.0%N/A0.276%
2/6/2020Victory Capital Management Inc.1,521$51K0.0%N/A0.006%
2/6/2020State Street Corp125,243$3.90M0.0%N/A0.511%
2/5/2020American International Group Inc.6,738$0.21M0.0%N/A0.027%
2/5/2020Rhumbline Advisers6,986$0.22M0.0%N/A0.028%
Data available starting January 2016

See Full Table
Phathom Pharmaceuticals logo
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is based in Buffalo Grove, Illinois.
Read More

Today's Range

Now: $38.49
$37.32
$39.38

50 Day Range

MA: $43.09
$35.83
$48.68

52 Week Range

Now: $38.49
$27.47
$64.54

Volume

54,713 shs

Average Volume

104,114 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Phathom Pharmaceuticals?

Phathom Pharmaceuticals' top insider shareholders include:
  1. Terrie Curran (Insider)
  2. Azmi Nabulsi (COO)
  3. David A Socks (Director)
  4. Life Sciences Ix LP Frazier (Major Shareholder)
  5. Ra Capital Management, LP (Major Shareholder)
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel